News
Follow-ons lead a mixed first half of 2026 for med-tech financing
21+ hour, 24+ min ago (28+ words) Bio World News Follow-ons lead a mixed first half of 2026 for med-tech financing...
Large VC financings improve in H1 2026
21+ hour, 24+ min ago (16+ words) Bio World News Large VC financings improve in H1 2026...
In 2nd deal of week, Ipsen buys Memo's kidney transplant antibody
21+ hour, 24+ min ago (26+ words) Bio World News In 2nd deal of week, Ipsen buys Memo's kidney transplant antibody...
Cool move" by Zimmer part of med-tech"s tuck-in deals trend
21+ hour, 24+ min ago (29+ words) Bio World News Cool move" by Zimmer part of med-tech"s tuck-in deals trend...
SUCNR1 antagonist reverses tumor immune suppression
1+ day, 24+ min ago (14+ words) Bio World News SUCNR1 antagonist reverses tumor immune suppression...
HK biotech listings gain traction in Q2 with trio of June IPOs
16+ hour, 25+ min ago (26+ words) Bio World News HK biotech listings gain traction in Q2 with trio of June IPOs...
Some clinical trials in China under US congressional scrutiny
16+ hour, 12+ min ago (20+ words) Bio World News Some clinical trials in China under US congressional scrutiny...
Trex Bio discloses TRB-071 as CD30 agonist antibody
1+ day, 24+ min ago (20+ words) Bio World News Trex Bio discloses TRB-071 as CD30 agonist antibody...
MED-EL acquires gene therapy programs from Rescue Hearing
1+ day, 24+ min ago (20+ words) Bio World News MED-EL acquires gene therapy programs from Rescue Hearing...
Corxel-Vincentage's oral GLP-1 meets phase II obesity endpoints
1+ day, 20+ hour ago (24+ words) Bio World News Corxel-Vincentage's oral GLP-1 meets phase II obesity endpoints...